ILLUMINA Funding: How Much Did They Raise & Key Investors

How Much Did ILLUMINA Raise?
Funding & Key Investors

Illumina, Inc. has solidified its position as a dominant force in the global genomics sector, recently securing a major strategic investment totaling $750M. This latest infusion of capital brings the company's cumulative financial backing to $846M, underscoring its sustained relevance in the high-stakes market of genetic and genomic analysis. By leveraging this liquidity, the firm continues to reinforce its operational infrastructure and research capabilities, ensuring it remains at the forefront of precision medicine and diagnostic innovation.

The company's financial history reflects a long-term commitment to scaling its technological footprint. From its initial public offering and early stock issuances to its recent debt-based financing, Illumina has demonstrated a disciplined approach to capital management. This strategic trajectory highlights the firm's ability to attract significant institutional support, enabling it to maintain its competitive edge in a rapidly evolving life sciences landscape.

What is ILLUMINA?

ILLUMINA

Manufacturing

Test & Measurement Equipment

Healthcare Software

Headquartered in San Diego, California, Illumina, Inc. is a premier provider of sequencing- and array-based solutions for genetic and genomic analysis. The company operates through two primary segments: Core Illumina and GRAIL. Its extensive product portfolio includes advanced sequencing instruments, consumables, and specialized kits for whole-genome and targeted resequencing. Beyond hardware, the firm offers comprehensive services including genotyping and noninvasive prenatal testing. Through its GRAIL segment, Illumina is pioneering multi-cancer early detection tests, such as Galleri, which represent a significant shift toward proactive, blood-based diagnostic applications. The company serves a diverse global clientele, ranging from academic research institutions and government laboratories to pharmaceutical giants and commercial molecular diagnostic providers.

How much funding has ILLUMINA raised?

ILLUMINA has raised a total of $846M across 2 funding rounds:

2000

Stock Offering

$96M

2023

Debt

$750M

Stock Issuance/Offering (2000): $96M, investors not publicly disclosed

Debt (2023): $750M led by Bank of America

Key Investors in ILLUMINA

Bank of America

Bank of America is a global financial services institution that provides a comprehensive range of banking, investment, asset management, lending, and risk management solutions to individuals, businesses, corporations, governments, and institutional clients.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for ILLUMINA?

With the recent influx of capital, Illumina is well-positioned to accelerate its development of next-generation diagnostic solutions. The company's strategic roadmap focuses on enhancing its blood-based detection capabilities for minimal residual disease and expanding its post-diagnostic application suite. By prioritizing R&D in genomic research and clinical diagnostics, Illumina aims to deepen its market penetration within the biotechnology and healthcare sectors. As the demand for precision medicine continues to rise, the firm's ability to integrate its sequencing technology into clinical workflows will be a critical driver of its future growth and long-term value creation for stakeholders.

See full ILLUMINA company page

See More Financial Insights

No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Ring

Manufacturing

Telecommunication Equipment

Security Software

Software

Create-A-Pack Foods

Food & Beverage

Manufacturing

Elegant Packaging

Manufacturing

Pulp & Paper

Plastic, Packaging & Containers

Textiles & Apparel

GNW Machine

Industrial Machinery & Equipment

Manufacturing

Frequently Asked Questions Regarding ILLUMINA Financial Insights

What are the most recent funding rounds that ILLUMINA has completed, and what were the funding rounds?

ILLUMINA has recently completed 2 funding rounds: Debt on Jan 5, 2023, Stock Offering on Jul 27, 2000.

What is the total amount of funding ILLUMINA has raised to date?

ILLUMINA has raised a total of $846M in funding to date.

How many funding rounds has ILLUMINA completed?

ILLUMINA has completed 2 funding rounds.

How much funding did ILLUMINA raise in its most recent funding round?

ILLUMINA raised $750M in its most recent funding round.

Who are the lead investors in ILLUMINA's latest funding round?

The lead investor in ILLUMINA's latest funding round was Bank of America. To access investor data and explore similar companies, sign up for ZoomInfo.

Which was the largest funding round in ILLUMINA's history?

The largest funding round in ILLUMINA's history was $750M.

See more information about ILLUMINA